# A Study of Oncolytic Virus Injection (RT-01) in Patients With Extensive-Stage Small Cell Lung Cancer

> **NCT05205421** · PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital of Bengbu Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** Oncolytic Virus Injection(RT-01)

## Key facts

- **NCT ID:** NCT05205421
- **Lead sponsor:** The First Affiliated Hospital of Bengbu Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-18
- **Primary completion:** 2023-01
- **Final completion:** 2024-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05205421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05205421, "A Study of Oncolytic Virus Injection (RT-01) in Patients With Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05205421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*